埃塞俄比亚引入肺炎球菌疫苗12年后的肺炎球菌携带率、血清型分布与疫苗覆盖率
2023年在埃塞俄比亚东部和西南部城乡开展横断面调查,纳入2006名全年龄段参与者。农村地区全血清型肺炎球菌携带年龄标化患病率东部为56%(95%CI 48-64%)、西南部为26%(95%CI 20-31%),城市东部15%(95%CI 11-20%)、西南部16%(95%CI 12-19%)。5岁以下儿童PCV13血清型携带率城市7.4-9.3%、农村16-22%;接种卡记录的PCV第三剂覆盖率城市49%-87%、农村13-22%。
要点
- 农村地区肺炎球菌携带率高于城市,东部农村年龄标化患病率达56%。
- 5岁以下儿童PCV13血清型携带率农村16-22%,城市7.4-9.3%。
- 接种卡记录的PCV第三剂覆盖率农村仅13-22%,远低于城市49%-87%。
核心结论
- 埃塞俄比亚引入PCV12年后仍存在相当程度的疫苗血清型残留循环,农村地区和东部尤为明显,且疫苗覆盖率低。
- 肺炎球菌流行病学因地理区域和城乡环境而异,提示全国肺炎球菌疾病负担不均衡。
研究设计与样本
- 2023年在埃塞俄比亚东部和西南部城乡开展横断面调查。
- 通过Harar、Kersa和Gilgel Gibe人口监测系统的人口登记册以及Jimma市随机GPS点,在10个年龄组(<1、1-2、3-4、5-9、10-14、15-19、20-39、40-49、50-59和≥60岁)各随机选取50名参与者。
- 共纳入2006名参与者,采集社会经济特征和疫苗覆盖率数据,并采集单份鼻咽拭子进行肺炎球菌培养,采用乳胶凝集试验和确认性荚膜肿胀反应进行血清分型。
主要发现
- 农村地区全血清型肺炎球菌携带的年龄标化人群患病率东部为56%(95%CI 48-64%),西南部为26%(95%CI 20-31%)。
- 城市地区全血清型肺炎球菌携带的年龄标化人群患病率东部为15%(95%CI 11-20%),西南部为16%(95%CI 12-19%)。
- 5岁以下儿童PCV13血清型携带率城市地区为7.4-9.3%,农村地区为16-22%。
- 5岁以下参与者接种卡记录的PCV第三剂覆盖率城市地区为49%-87%,农村地区为13-22%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Ethiopia introduced the 10-valent pneumococcal conjugate vaccine (PCV10, GlaxoSmithKline plc.) in 2011 and switched to 13-valent vaccine (PCV13, Pfizer Inc.) in 2020. In 2023, we conducted a study in four settings in Ethiopia to determine the vaccine coverage, residual vaccine-type carriage prevalence, serotype distribution, and factors associated with carriage across all age groups. METHODS: A cross-sectional survey was conducted in urban and rural areas of eastern and southwest Ethiopia in 2023. In total, 50 participants in each of 10 age groups (<1, 1-2, 3-4, 5-9, 10-14, 15-19, 20-39, 40-49, 50-59, and ≥ 60 years) were randomly selected using population registers in Harar, Kersa and Gilgel Gibe demographic surveillance systems, and using random GPS points for Jimma city. After informed consent, data on socioeconomic characteristics and vaccine coverage were collected. A single nasopharyngeal swab was collected and cultured for pneumococci. Pneumococci were serotyped using latex agglutination and confirmatory Quellung reaction. RESULTS: A total of 2006 participants were enrolled. The age-standardized population prevalence of pneumococcal carriage (all serotypes) in rural settings was 56 % (95 %CI 48-64 %) in the east and 26 % (95 %CI 20-31 %) in the southwest, and in urban settings, 15 % (95 %CI 11-20 %) in the east and 16 % (95 %CI 12-19 %) in the southwest. PCV13 serotype carriage prevalence among children aged <5 years ranged from 7.4 to 9.3 % in the urban areas, to 16-22 % in the rural areas. Coverage of the third dose of PCV, recorded in vaccination cards of participants aged <5 years, was 49 %-87 % in the urban areas; it was much lower at 13-22 % in the rural areas. CONCLUSIONS: There is considerable residual circulation of vaccine serotypes in Ethiopia, particularly in rural areas and the east, and low vaccine coverage. Pneumococcal epidemiology varies by geographical region and urban/rural setting, implying an unequal burden of pneumococcal disease across the country 12 years post-PCV introduction.
引用
- Bizuayehu HY, Kebede Y, Deressa M, et al. Pneumococcal carriage prevalence, serotype distribution, and vaccine coverage in Ethiopia 12 years after pneumococcal vaccine introduction. Vaccine. 2025. PMID: 40966977. doi:10.1016/j.vaccine.2025.127762
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。